Signal Transduction Inhibitors in the Treatment of Breast Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
201-216
Author(s):
Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva
Pharmacogenetics of Irinotecan
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
225-237
Author(s):
G. Toffoli, E. Cecchin, G. Corona and M. Boiocchi
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis
Pharmacological Characteristics of Parenteral IGF-I Administration
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
123-140
Author(s):
J. Torrado and C. Carrascosa
Preface
Journal:
Current Drug Targets
Volume:
4
Page:
i-i
Author(s):
Martin Tenniswood
TGF-ß / Smad Signaling in Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
197-207
Author(s):
Diana Bello-DeOcampo and Donald J. Tindall
Par-4 for Molecular Therapy of Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
223-230
Author(s):
James Butler and Vivek M. Rangnekar
From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee
Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
89-107
Author(s):
Rajendra Sharma, Yogesh C. Awasthi, Yusong Yang, Abha Sharma, Sharad S. Singhal and Sanjay Awasthi
Survivin: Role in Normal Cells and in Pathological Conditions
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
131-152
Author(s):
L. O'Driscoll, R. Linehan and M. Clynes